Schrodinger (SDGR) closed at $28.77 on November 5, 2026, up 0.9% from the previous close, on volume of 2,042,182 shares (30-day average 2,194,129).
Data as of November 5, 2026.
5-Nov-2026
Morgan Stanley Keeps Their Hold Rating on Schrodinger (SDGR)
TipRanks (Thu, 5-Nov 8:47 AM ET)
Analysts Are Bullish on Top Healthcare Stocks: Schrodinger (SDGR), Alnylam Pharma (ALNY)
TipRanks (Thu, 5-Nov 8:30 AM ET)
Schrf6dinger (SDGR) lifts 2026 ACV outlook after 17% Q3 contract growth
Market Chameleon (Thu, 5-Nov 2:55 AM ET)
Schrödinger Clarifies Clinical Study Status and Reports Third-Quarter Results
TipRanks (Wed, 4-Nov 4:48 PM ET)
Schrödinger GAAP EPS of -$0.50 beats by $0.17, revenue of $64.49M beats by $16.86M
Seeking Alpha News (Wed, 4-Nov 4:17 PM ET)
Schrdinger Reports Third Quarter 2026 Financial Results
Business Wire (Wed, 4-Nov 4:05 PM ET)
Schrdinger to Present at UBS Global Healthcare Conference
Business Wire (Wed, 28-Oct 8:30 AM ET)
Schrdinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Mon, 26-Oct 8:30 AM ET)
Schrdinger to Announce Third Quarter 2026 Financial Results on November 4
Business Wire (Wed, 21-Oct 8:30 AM ET)
Market Chameleon (Thu, 15-Oct 4:05 AM ET)
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
Schrodinger trades on the NASDAQ stock market under the symbol SDGR.
As of November 5, 2026, SDGR stock price climbed to $28.77 with 2,042,182 million shares trading.
SDGR has a beta of 1.88, meaning it tends to be more sensitive to market movements. SDGR has a correlation of 0.10 to the broad based SPY ETF.
SDGR has a market cap of $2.15 billion. This is considered a Mid Cap stock.
Last quarter Schrodinger reported $64 million in Revenue and -$.50 earnings per share. This beat revenue expectation by $17 million and exceeded earnings estimates by $.16.
In the last 3 years, SDGR traded as high as $38.00 and as low as $10.95.
The top ETF exchange traded funds that SDGR belongs to (by Net Assets): IJR, ARKG, VTI, VB, IWM.
SDGR has outperformed the market in the last year with a price return of +43.9% while the SPY ETF gained +9.7%. SDGR has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +83.8% and +20.4%, respectively, while the SPY returned -4.7% and -5.2%, respectively.
SDGR support price is $26.98 and resistance is $30.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SDGR shares will trade within this expected range on the day.
